KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Charles River Laboratories International (CRL) Other Gross PP&E Adjustments: 2009-2025

Historic Other Gross PP&E Adjustments for Charles River Laboratories International (CRL) over the last 12 years, with Sep 2025 value amounting to $2.7 billion.

  • Charles River Laboratories International's Other Gross PP&E Adjustments fell 0.18% to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 billion, marking a year-over-year increase of 1.90%. This contributed to the annual value of $2.6 billion for FY2024, which is 2.50% up from last year.
  • As of Q3 2025, Charles River Laboratories International's Other Gross PP&E Adjustments stood at $2.7 billion, which was down 0.15% from $2.7 billion recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Other Gross PP&E Adjustments ranged from a high of $2.7 billion in Q3 2024 and a low of -$408.5 million during Q2 2023.
  • Its 3-year average for Other Gross PP&E Adjustments is $1.8 billion, with a median of $2.6 billion in 2024.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 69.10% in 2021, then surged by 824.26% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Other Gross PP&E Adjustments (Quarterly) stood at $2.1 billion in 2021, then rose by 6.37% to $2.2 billion in 2022, then grew by 15.48% to $2.6 billion in 2023, then grew by 2.50% to $2.6 billion in 2024, then dropped by 0.18% to $2.7 billion in 2025.
  • Its Other Gross PP&E Adjustments was $2.7 billion in Q3 2025, compared to $2.7 billion in Q2 2025 and $2.6 billion in Q1 2025.